Literature DB >> 11888578

Individualising HIV treatment--pharmacogenetics and immunogenetics.

Amalio Telenti1, Vincent Aubert, François Spertini.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11888578     DOI： 10.1016/S0140-6736(02)07899-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.

Authors:  Gabriela Bleiber; Margaret May; Raquel Martinez; Pascal Meylan; Jürg Ott; Jacques S Beckmann; Amalio Telenti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Online registry of genetic and clinical immunodeficiency diagnostic laboratories, IDdiagnostics.

Authors:  Crina Samarghitean; Jouni Väliaho; Mauno Vihinen
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

3.  Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.

Authors:  Angela Ciuffi; Gabriela Bleiber; Miguel Muñoz; Raquel Martinez; Corinne Loeuillet; Manuela Rehr; Marek Fischer; Huldrych F Günthard; Annette Oxenius; Pascal Meylan; Sebastian Bonhoeffer; Didier Trono; Amalio Telenti
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.

Authors:  Alexandra Trkola; Herbert Kuster; Christine Leemann; Claudia Ruprecht; Beda Joos; Amalio Telenti; Bernhard Hirschel; Rainer Weber; Sebastian Bonhoeffer; Huldrych F Günthard
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.

Authors:  Beda Joos; Alexandra Trkola; Marek Fischer; Herbert Kuster; Peter Rusert; Christine Leemann; Jürg Böni; Annette Oxenius; David A Price; Rodney E Phillips; Joseph K Wong; Bernard Hirschel; Rainer Weber; Huldrych F Günthard
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods.

Authors:  Laura Stocchi; Raffaella Cascella; Stefania Zampatti; Antonella Pirazzoli; Giuseppe Novelli; Emiliano Giardina
Journal:  Curr Genomics       Date:  2012-06       Impact factor: 2.236
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.